• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

摩洛哥进行性骨化性纤维发育不良患者中 ACVR1 基因罕见突变。

Rarely occurring mutation of ACVR1 gene in Moroccan patient with fibrodysplasia ossificans progressiva.

机构信息

Department of Medical Genetics, National Institute of Health, 27 Avenue Ibn Batouta, BP 769, 11400, Rabat, Morocco.

出版信息

Clin Rheumatol. 2010 Jan;29(1):119-21. doi: 10.1007/s10067-009-1283-z. Epub 2009 Oct 1.

DOI:10.1007/s10067-009-1283-z
PMID:19795179
Abstract

Fibrodysplasia ossificans progressiva (FOP, MIM 135100) is a rare autosomal dominant disorder characterized by postnatal progressive heterotopic ossification of the connective tissue and congenital malformation of the big toes. Recently, FOP has been associated with a specific mutation of ACVR1, the gene coding for a bone morphogenetic protein type I receptor. We report the case of a Moroccan patient with FOP carrying a rarely occurring mutation of ACVR1 gene.

摘要

进行性骨化性纤维发育不良(FOP,MIM 135100)是一种罕见的常染色体显性遗传疾病,其特征是出生后结缔组织的进行性异位骨化和大脚趾的先天性畸形。最近,FOP 与 ACVR1 基因的特定突变有关,该基因编码骨形态发生蛋白 I 型受体。我们报告了一例携带 ACVR1 基因突变的摩洛哥 FOP 患者。

相似文献

1
Rarely occurring mutation of ACVR1 gene in Moroccan patient with fibrodysplasia ossificans progressiva.摩洛哥进行性骨化性纤维发育不良患者中 ACVR1 基因罕见突变。
Clin Rheumatol. 2010 Jan;29(1):119-21. doi: 10.1007/s10067-009-1283-z. Epub 2009 Oct 1.
2
BMP signaling and skeletal development in fibrodysplasia ossificans progressiva (FOP).骨纤维发育不良性骨化症(FOP)中的 BMP 信号和骨骼发育。
Dev Dyn. 2022 Jan;251(1):164-177. doi: 10.1002/dvdy.387. Epub 2021 Jun 26.
3
The ACVR1 R206H mutation found in fibrodysplasia ossificans progressiva increases human induced pluripotent stem cell-derived endothelial cell formation and collagen production through BMP-mediated SMAD1/5/8 signaling.在进行性骨化性纤维发育不良中发现的ACVR1 R206H突变通过BMP介导的SMAD1/5/8信号通路增加人诱导多能干细胞衍生的内皮细胞形成和胶原蛋白生成。
Stem Cell Res Ther. 2016 Aug 17;7(1):115. doi: 10.1186/s13287-016-0372-6.
4
Fibrodysplasia ossificans progressiva: middle-age onset of heterotopic ossification from a unique missense mutation (c.974G>C, p.G325A) in ACVR1.进行性骨化性纤维发育不良:ACVR1 中独特的错义突变(c.974G>C,p.G325A)导致中年发病的异位骨化。
J Bone Miner Res. 2012 Mar;27(3):729-37. doi: 10.1002/jbmr.1473.
5
ACVR1 (587T>C) mutation in a variant form of fibrodysplasia ossificans progressiva: second report.进行性骨化性纤维发育不良变异型中的ACVR1(587T>C)突变:第二篇报告。
Am J Med Genet A. 2014 Jan;164A(1):220-4. doi: 10.1002/ajmg.a.36219. Epub 2013 Nov 20.
6
A case of Fibrodysplasia Ossificans Progressiva associated with a novel variant of the ACVR1 gene.一例与 ACVR1 基因新型变异相关的进行性骨化性纤维发育不良。
Mol Genet Genomic Med. 2021 Oct;9(10):e1774. doi: 10.1002/mgg3.1774. Epub 2021 Aug 4.
7
Skeletal malformations and developmental arthropathy in individuals who have fibrodysplasia ossificans progressiva.纤维性骨发育不良所致骨化性肌炎患者的骨骼畸形和发育性关节病。
Bone. 2020 Jan;130:115116. doi: 10.1016/j.bone.2019.115116. Epub 2019 Oct 23.
8
Classic and atypical fibrodysplasia ossificans progressiva (FOP) phenotypes are caused by mutations in the bone morphogenetic protein (BMP) type I receptor ACVR1.典型和非典型进行性骨化性纤维发育不良(FOP)表型是由骨形态发生蛋白(BMP)I型受体ACVR1中的突变引起的。
Hum Mutat. 2009 Mar;30(3):379-90. doi: 10.1002/humu.20868.
9
Overexpression of Wild-Type ACVR1 in Fibrodysplasia Ossificans Progressiva Mice Rescues Perinatal Lethality and Inhibits Heterotopic Ossification.野生型 ACVR1 在进行性骨化性纤维发育不良小鼠中的过表达可挽救围产期致死性并抑制异位骨化。
J Bone Miner Res. 2022 Nov;37(11):2077-2093. doi: 10.1002/jbmr.4617. Epub 2022 Jul 3.
10
Fibrodysplasia ossificans progressiva: clinical and genetic aspects.进行性骨化性纤维发育不良:临床与遗传方面。
Orphanet J Rare Dis. 2011 Dec 1;6:80. doi: 10.1186/1750-1172-6-80.

引用本文的文献

1
Fibrodysplasia ossificans progressiva: genetic and clinical characterization in a cohort of Polish patients and review of potential therapies.进行性骨化性纤维发育不良:一组波兰患者的遗传学和临床特征及潜在治疗方法综述
J Appl Genet. 2025 Apr 12. doi: 10.1007/s13353-025-00966-4.
2
Pay Attention to the Osteochondromas in Fibrodysplasia Ossificans Progressiva.关注进行性骨化性纤维发育不良中的骨软骨瘤。
Orthop Surg. 2024 Mar;16(3):781-787. doi: 10.1111/os.13956. Epub 2024 Jan 7.
3
Navigating the Complex Landscape of Fibrodysplasia Ossificans Progressiva: From Current Paradigms to Therapeutic Frontiers.

本文引用的文献

1
Classic and atypical fibrodysplasia ossificans progressiva (FOP) phenotypes are caused by mutations in the bone morphogenetic protein (BMP) type I receptor ACVR1.典型和非典型进行性骨化性纤维发育不良(FOP)表型是由骨形态发生蛋白(BMP)I型受体ACVR1中的突变引起的。
Hum Mutat. 2009 Mar;30(3):379-90. doi: 10.1002/humu.20868.
2
Mutational analysis of the ACVR1 gene in Italian patients affected with fibrodysplasia ossificans progressiva: confirmations and advancements.意大利进行性骨化性纤维发育不良患者ACVR1基因的突变分析:验证与进展
Eur J Hum Genet. 2009 Mar;17(3):311-8. doi: 10.1038/ejhg.2008.178. Epub 2008 Oct 1.
3
探索进行性骨化性纤维发育不良的复杂领域:从现有范式到治疗前沿。
Genes (Basel). 2023 Nov 30;14(12):2162. doi: 10.3390/genes14122162.
4
A blocking monoclonal antibody reveals dimerization of intracellular domains of ALK2 associated with genetic disorders.一种阻断性单克隆抗体揭示了与遗传疾病相关的 ALK2 细胞内结构域的二聚化。
Nat Commun. 2023 May 25;14(1):2960. doi: 10.1038/s41467-023-38746-5.
5
A case of Fibrodysplasia Ossificans Progressiva associated with a novel variant of the ACVR1 gene.一例与 ACVR1 基因新型变异相关的进行性骨化性纤维发育不良。
Mol Genet Genomic Med. 2021 Oct;9(10):e1774. doi: 10.1002/mgg3.1774. Epub 2021 Aug 4.
6
Accumulated Knowledge of Activin Receptor-Like Kinase 2 (ALK2)/Activin A Receptor, Type 1 (ACVR1) as a Target for Human Disorders.作为人类疾病靶点的激活素受体样激酶2(ALK2)/激活素A受体1型(ACVR1)的累积知识。
Biomedicines. 2021 Jun 26;9(7):736. doi: 10.3390/biomedicines9070736.
7
Genetic and Acquired Heterotopic Ossification: A Translational Tale of Mice and Men.遗传与后天性异位骨化:小鼠与人类的转化故事
Biomedicines. 2020 Dec 14;8(12):611. doi: 10.3390/biomedicines8120611.
8
ACVR1 Function in Health and Disease.ACVR1 在健康和疾病中的作用。
Cells. 2019 Oct 31;8(11):1366. doi: 10.3390/cells8111366.
9
The Horizon of a Therapy for Rare Genetic Diseases: A "Druggable" Future for Fibrodysplasia Ossificans Progressiva.罕见遗传性疾病治疗的新曙光:成骨不全性骨纤维发育异常的“可成药”未来。
Int J Mol Sci. 2018 Mar 26;19(4):989. doi: 10.3390/ijms19040989.
10
Fibrodysplasia ossificans progressiva: Basic understanding and experimental models.进行性骨化性纤维发育不良:基本认识与实验模型
Intractable Rare Dis Res. 2017 Nov;6(4):242-248. doi: 10.5582/irdr.2017.01055.
A unique case of fibrodysplasia ossificans progressiva with an ACVR1 mutation, G356D, other than the common mutation (R206H).
一例独特的进行性骨化性纤维发育不良病例,其携带ACVR1基因的G356D突变,而非常见的R206H突变。
Am J Med Genet A. 2008 Feb 15;146A(4):459-63. doi: 10.1002/ajmg.a.32151.
4
The ACVR1 617G>A mutation is also recurrent in three Japanese patients with fibrodysplasia ossificans progressiva.ACVR1基因617G>A突变在三名日本进行性骨化性纤维发育不良患者中也反复出现。
J Hum Genet. 2007;52(5):473-475. doi: 10.1007/s10038-007-0128-3. Epub 2007 Mar 10.
5
De novo 617G-A nucleotide mutation in the ACVR1 gene in a Taiwanese patient with fibrodysplasia ossificans progressiva.一名台湾进行性骨化性纤维发育不良患者ACVR1基因出现新生617G-A核苷酸突变。
J Hum Genet. 2006;51(12):1083-1086. doi: 10.1007/s10038-006-0069-2. Epub 2006 Nov 1.
6
A recurrent mutation in the BMP type I receptor ACVR1 causes inherited and sporadic fibrodysplasia ossificans progressiva.骨形态发生蛋白I型受体ACVR1中的复发性突变会导致遗传性和散发性进行性骨化性纤维发育不良。
Nat Genet. 2006 May;38(5):525-7. doi: 10.1038/ng1783. Epub 2006 Apr 23.
7
Bone morphogenetic proteins.骨形态发生蛋白
Growth Factors. 2004 Dec;22(4):233-41. doi: 10.1080/08977190412331279890.
8
Heterotopic ossification.异位骨化
J Am Acad Orthop Surg. 2004 Mar-Apr;12(2):116-25. doi: 10.5435/00124635-200403000-00007.
9
Conductive hearing loss in individuals with fibrodysplasia ossificans progressiva.进行性骨化性纤维发育不良患者的传导性听力损失。
Am J Audiol. 1999 Jun;8(1):29-33. doi: 10.1044/1059-0889(1999/011).
10
Fibrodysplasia (myositis) ossificans progressiva. Clinical lessons from a rare disease.进行性骨化性纤维发育不良(骨化性肌炎)。一种罕见疾病的临床经验。
Clin Orthop Relat Res. 1998 Jan(346):7-14.